Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Managing multiple autoimmune diseases in one patient is very challenging.

Zinc treatment improved skin and hair issues in a boy with a zinc-related condition.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

PRP may help short-term with ankle arthritis pain, but long-term effects are unclear.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Chronic Acrodermatitis Enteropathica can persist into adulthood and requires careful zinc treatment.

Oral zinc therapy is effective for treating acrodermatitis enteropathica.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Social media can help compare the effectiveness and safety of new arthritis medications.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Upadacitinib improved multiple immune-related conditions in one patient.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Methotrexate plus prednisolone had the fewest serious side effects.

More research is needed to understand and manage rheumatoid arthritis better.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.